Home Applications 210272 Application 210272
Type ANDA
Sponsor AVEVA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 BUPRENORPHINE BUPRENORPHINE FILM, EXTENDED RELEASE;TRANSDERMAL 5MCG/HR No No 002 BUPRENORPHINE BUPRENORPHINE FILM, EXTENDED RELEASE;TRANSDERMAL 7.5MCG/HR No No 003 BUPRENORPHINE BUPRENORPHINE FILM, EXTENDED RELEASE;TRANSDERMAL 10MCG/HR No No 004 BUPRENORPHINE BUPRENORPHINE FILM, EXTENDED RELEASE;TRANSDERMAL 15MCG/HR No No 005 BUPRENORPHINE BUPRENORPHINE FILM, EXTENDED RELEASE;TRANSDERMAL 20MCG/HR No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A210272-001 BUPRENORPHINE BUPRENORPHINE 5MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 A210272-002 BUPRENORPHINE BUPRENORPHINE 7.5MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 A210272-003 BUPRENORPHINE BUPRENORPHINE 10MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 A210272-004 BUPRENORPHINE BUPRENORPHINE 15MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 A210272-005 BUPRENORPHINE BUPRENORPHINE 20MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 5 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 5 of 5 · 185 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A210272-001 BUPRENORPHINE 5MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A210272-002 BUPRENORPHINE 7.5MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A210272-003 BUPRENORPHINE 10MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A210272-004 BUPRENORPHINE 15MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A210272-005 BUPRENORPHINE 20MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A210272-001 BUPRENORPHINE 5MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A210272-002 BUPRENORPHINE 7.5MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A210272-003 BUPRENORPHINE 10MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A210272-004 BUPRENORPHINE 15MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A210272-005 BUPRENORPHINE 20MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A210272-001 BUPRENORPHINE 5MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 e64feba35796…2022-09-29 23:25 UTC 2022-09 A210272-002 BUPRENORPHINE 7.5MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 e64feba35796…2022-09-29 23:25 UTC 2022-09 A210272-003 BUPRENORPHINE 10MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 e64feba35796…2022-09-29 23:25 UTC 2022-09 A210272-004 BUPRENORPHINE 15MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 e64feba35796…2022-09-29 23:25 UTC 2022-09 A210272-005 BUPRENORPHINE 20MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A210272-001 BUPRENORPHINE 5MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A210272-002 BUPRENORPHINE 7.5MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A210272-003 BUPRENORPHINE 10MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A210272-004 BUPRENORPHINE 15MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A210272-005 BUPRENORPHINE 20MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A210272-001 BUPRENORPHINE 5MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A210272-002 BUPRENORPHINE 7.5MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A210272-003 BUPRENORPHINE 10MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A210272-004 BUPRENORPHINE 15MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A210272-005 BUPRENORPHINE 20MCG/HR FILM, EXTENDED RELEASE / TRANSDERMAL AB 2021-09-23 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 185 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 15 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 60505-7075 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7075 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7075 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7076 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7076 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7076 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7077 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7077 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7077 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7078 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7078 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7078 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7079 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7079 Buprenorphene Buprenorphene Apotex Corp. ANDA Current 60505-7079 Buprenorphene Buprenorphene Apotex Corp. ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 76479 ORIG 2023-11-07